• Blog
  • Immunofluorescence Assays Market Report

    Immunofluorescence Assays Market Report

    Immunofluorescence Assays Market Report
    Report code - SR1504 Delivery - 2 Weeks
    Get Free Sample |
    Immunofluorescence Assays Market Trends, Dynamics & Market Insights
    See more...

    Market Insights

    The Immunofluorescence Assays Market is estimated to grow from USD 2.5 billion in 2020 to USD 3.6 billion by 2026 at a healthy CAGR of 6.3% during the forecast period.

    Figure: Immunofluorescence Assays Market Size, 2020-2026 (USD Billion)

    Immunofluorescence-Assays-Market-Forecast

    Wish to get a free sample? Register Here

    What is immunofluorescene?

    Immunofluorescence is a light microscopy method with a fluorescence microscope, which is primarily used on microbiological samples. This technique employs the sensitivity of antibodies to their antigen to guide fluorescent dyes to specific biomolecule targets inside a cell, enabling visualization of the target molecule's distribution within the sample.

    Key Players

    Key players operating in the immunofluorescence assays market are-

    • Thermo Fisher Scientific Inc. (US)
    • Inova Diagnostics, Inc. (US)
    • Bio-Rad Laboratories, Inc. (US)
    • Abcam (UK)
    • PerkinElmer Inc. (US)
    • Merck Millipore (US)
    • Cell Signaling Technology (US)
    • MEDIPAN GMBH (Germany)
    • Sino Biological (China)
    • Danaher Corporation (US).

    Market Dynamics

    The growing prevalence of chronic and infectious diseases such as rheumatoid arthritis, cancer, Alzheimer’s, HIV AIDS, and Parkinson’s are likely to augment the immunofluorescence assay market in the coming years. Moreover, the rising R&D spending & healthcare expenditure further boost the market growth. However, the high cost of assay kits and screening instruments is anticipated to hinder the industry growth. Nevertheless, the developing economies of Brazil, China, and India are expected to offer potential growth opportunities in the following years.

    Segments' Analysis

    Type Trends

    Based on type, the market has been classified into indirect immunofluorescence and direct immunofluorescence. The indirect immunofluorescence segment accounted for a substantial market share in 2020. The benefits of indirect immunofluorescence are high sensitivity and easy to change signal color based on changing the second antibody which can get commercially. The labeled second antibodies are easily obtained. Secondary antibodies are relatively cheaper than primary antibodies, which further boosts the segment growth.

    Regional Trend

    The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to favorable government initiatives, established healthcare infrastructure, and the high prevalence of infectious diseases and cancer in the region, which is likely to boost regional growth. Moreover, beneficial government initiatives and a rise in the number of research partnerships further proliferates regional growth.

    COVID-19 Impact on Immunofluorescence Assays Market

    The COVID-19 outbreak positively influenced the growth of the immunofluorescence assays market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. The COVID-19 pandemic has increased the demand for immunofluorescence assays as people are consuming immunity-booster products to increase immunity to prevent the transmission of coronavirus around the globe. Hence, several manufacturers are trying to develop new products to keep up with the high demand, thus boosting the market growth.

    • What are the key trends in the immunofluorescence assays market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the immunofluorescence assays market?
    • What are the key strategies adopted by the major vendors to lead in the immunofluorescence assays market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the immunofluorescence assays market hopes to have the greatest opportunity to convert-

    • Immunofluorescence Assays distributors
    • Immunofluorescence Assays suppliers
    • Immunofluorescence Assays manufacturers
    • Hospitals
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The immunofluorescence assays market is expected to witness an impressive growth of 6.3% CAGR in the coming years.

    Thermo Fisher Scientific Inc. (US), Inova Diagnostics, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abcam (UK), PerkinElmer Inc. (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), and Danaher Corporation (US) are among the key players in the immunofluorescence assays market.

    The immunofluorescence assays market size is expected to reach USD 3.6 billion in the foreseeable future.

    Indirect immunofluorescence segment accounted for a substantial share in the immunofluorescence assays market in 2020.

    North America is expected to remain dominant in the immunofluorescence assays market in the next five years.

    Immunofluorescence Assays distributors, Immunofluorescence Assays suppliers, Immunofluorescence Assays manufacturers, Hospitals, Government bodies are the target audience in the immunofluorescence assays market.

    •   
    ×